UnitedHealth Group Stock Performance
UnitedHealth Group shares closed at $404.44, reflecting a daily decline of approximately 1.02%, per SID market data. Over the trailing one-month period, the stock has gained 7.67%, though the three-month return shows a modest decline of 1.74%. On a one-year basis, UNH has appreciated 17.19%, underscoring longer-term resilience despite near-term volatility. The stock currently trades above both its 50-day moving average of $390.40 and its 200-day moving average of $361.58, according to Massive/Polygon technical data, suggesting sustained upward momentum in the intermediate trend. The 14-day relative strength index stands at 62.0, indicating the stock remains below overbought territory. UNH carries a beta of 0.432, reflecting significantly lower volatility relative to the broader market. Average daily trading volume is approximately 8.77 million shares, supporting robust liquidity for the $305 billion market capitalization healthcare giant.
UnitedHealth Group Valuation Analysis
UnitedHealth Group currently trades at a price-to-earnings ratio of 17.38, per SID market data, positioning the company at a moderate valuation relative to the broader healthcare sector. The price-to-book ratio stands at 3.19, according to SEC filings, reflecting the market's premium for UNH's dominant managed care franchise and diversified Optum platform. The PEG ratio registers at negative 1.02, a figure that warrants contextual interpretation given potential shifts in forward earnings growth expectations following recent operational developments. UNH offers a dividend yield of approximately 2.59%, providing meaningful income relative to healthcare sector peers. With a market capitalization of approximately $305 billion, UnitedHealth remains the largest publicly traded health insurer. The current valuation metrics suggest the stock is trading at levels consistent with a large-cap healthcare operator navigating a complex regulatory and reimbursement environment while maintaining substantial cash return commitments to shareholders.
Smart Money Activity for UNH
UnitedHealth Group's composite smart money score stands at 41 out of 100, registering a neutral signal according to SID market data. Institutional positioning is exceptionally strong, scoring a perfect 25 out of 25, indicating broad and deep ownership among large asset managers per 13F institutional filings. In contrast, the insider sentiment score registers at 0.0 out of 25, despite notable recent activity: SEC Form 4 filings reveal 20 insider transactions over the past 90 days, all of which were purchases with zero sales recorded. This all-buy pattern among insiders suggests confidence from company executives, though the low insider score may reflect the size or timing characteristics of these transactions. Dark pool activity scores 12.2 out of 25, indicating moderate institutional block trading. Congressional trading activity registers at 4.0 out of 25, reflecting limited but present legislative member interest. The divergence between strong institutional holdings and the muted composite score highlights mixed signals across tracking dimensions for UNH.
UnitedHealth Group Earnings Outlook
UnitedHealth Group has delivered a consistent pattern of earnings beats across its most recent reporting quarters. In the April 2026 quarter, the company reported earnings per share of $7.23 against a consensus estimate of $6.56, representing a positive surprise of $0.67, according to company earnings reports. The July 2026 quarter showed an even more pronounced beat, with actual EPS of $6.38 versus the $4.85 estimate, a $1.53 upside surprise. Most recently, the October 2026 quarter delivered EPS of $4.69 compared to estimates of $4.14, a $0.55 positive surprise per analyst estimates. Looking ahead, the next earnings report is scheduled for October 27, 2026, with the current consensus estimate standing at $4.14 per share. The trailing three-quarter trend demonstrates UNH's ability to exceed Wall Street expectations, with cumulative positive surprises totaling $2.75 across those periods.
Wall Street Analyst Ratings for UNH
Wall Street consensus on UnitedHealth Group remains firmly bullish, with all five most recent analyst actions reiterating positive ratings, per SID consensus data. On October 27, 2026, both Wells Fargo and Morgan Stanley maintained their Overweight ratings on UNH, signaling continued conviction from two of the largest sell-side institutions. Mizuho reiterated its Outperform rating on October 22, while RBC Capital maintained its Outperform call on October 20, according to Wall Street analyst reports. JP Morgan also reaffirmed its Overweight stance on October 16. Notably, none of these five recent actions represented upgrades or downgrades; each was a maintenance of an already-positive thesis, reflecting stable and sustained institutional confidence. The unanimous bullish positioning across major banks stands in contrast to the stock's relatively moderate P/E ratio of 17.38 and its neutral smart money composite score of 41, suggesting analysts see fundamental value at current price levels that quantitative signals may not fully capture.
